LYZ and bacterial infectious disease: We propose that the engagement of host intestinal lysozyme with an enteric pathogen such as Salmonella promotes the release of barrier-impairing factors; therefore, elevated or abnormal lysozyme production is pro-inflammatory during pathogenic bacterial infection.